1248541-73-2 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 2,3-diamino-5-methylbenzoate is used as an intermediate for the synthesis of pharmaceuticals and organic compounds. Its unique structure with two amino groups and one methyl group allows it to be a versatile building block in the development of various medications.
Used in Antibacterial and Antifungal Medications:
Methyl 2,3-diamino-5-methylbenzoate has potential applications in the development of antibacterial and antifungal medications. Its chemical properties enable it to be incorporated into formulations that target and combat harmful microorganisms, contributing to the discovery of new treatments for infections.
Check Digit Verification of cas no
The CAS Registry Mumber 1248541-73-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,8,5,4 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1248541-73:
(9*1)+(8*2)+(7*4)+(6*8)+(5*5)+(4*4)+(3*1)+(2*7)+(1*3)=162
162 % 10 = 2
So 1248541-73-2 is a valid CAS Registry Number.
1248541-73-2Relevant academic research and scientific papers
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
Chen, Xuxing,Huan, Xiajuan,Liu, Qiufeng,Wang, Yuqin,He, Qian,Tan, Cun,Chen, Yi,Ding, Jian,Xu, Yechun,Miao, Zehong,Yang, Chunhao
, p. 389 - 403 (2018/01/17)
The nuclear protein poly(ADP-ribose) polymerases-1/2 (PARP-1/2) are involved in DNA repair damaged by endogenous or exogenous process. And PARP-1/2 inhibitors have been proved to be clinically efficacious for DNA repair deficient tumors in the past decade
DIHYDROOROTATE DEHYDROGENASE INHIBITORS
-
Page/Page column 79, (2010/11/03)
The invention relates to compounds of formula (I) wherein R1, R2, X1, X2, Y, Ra, Rb, Q have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis and also in the treatment of cancer disorders.
